Why are monoclonal antibodies dividing doctors treating Covid?

To ensure delivery to your inbox add email@mail.nbcnews.com to your contacts | View in browser Add NBC News to your contacts Unsubscribe from this email

Dec 20, 2020 Why are monoclonal antibodies dividing doctors treating Covid? Monoclonal antibodies are the only therapy authorized by the Food and Drug Administration so far that is meant to prevent patients from being hospitalized for Covid-19. But many doses sit untouched at health care facilities across the country, with providers reluctant to use them. "A lot of us in infectious disease aren't sure that the monoclonal antibodies are worth the effort," one infectious disease specialist said. Read More Get the NBC News Mobile App Follow NBC News Check out all of NBCNEWS Newsletters here. Update Preferences | Unsubscribe | Contact | Privacy Update Preferences Unsubscribe Contact Privacy